
Integra Holdings is a unique healthcare investment company with exclusive rights to first examine and invest in promising innovations and intellectual property emerging from the Hebrew University of Jerusalem. The company focuses on early to late-stage life sciences innovations in Pharma Biotechnology, medical devices, diagnostics, and AI. Integra Holdings employs a multidisciplinary team that provides hands-on support from inception to commercialization, leveraging an extensive industry network. Founded in 2012 by Yissum, the technology transfer company of the Hebrew University, Integra has a diversified portfolio of nine companies and partnerships with leading investment funds. It acts as a gateway to bring academic excellence and innovation to market, particularly in life sciences.

Integra Holdings is a unique healthcare investment company with exclusive rights to first examine and invest in promising innovations and intellectual property emerging from the Hebrew University of Jerusalem. The company focuses on early to late-stage life sciences innovations in Pharma Biotechnology, medical devices, diagnostics, and AI. Integra Holdings employs a multidisciplinary team that provides hands-on support from inception to commercialization, leveraging an extensive industry network. Founded in 2012 by Yissum, the technology transfer company of the Hebrew University, Integra has a diversified portfolio of nine companies and partnerships with leading investment funds. It acts as a gateway to bring academic excellence and innovation to market, particularly in life sciences.